BAAM
NTUS

Baker Avenue Asset Management’s Natus Medical Inc NTUS Stock Holding History

Baker Avenue Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,872
Closed -$744K – 282
2018
Q4 		$744K Buy
+21,872
New +$711K 0.07% 161

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Baker Avenue Asset Management's NTUS Position: Q1 2019 in Review

Baker Avenue Asset Management sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 21,872 shares — an estimated $744K sold.

Baker Avenue Asset Management first reported a position in NTUS in Q4 2018 and held it in 1 quarter. The position peaked at $744K in Q4 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Baker Avenue Asset Management reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Baker Avenue Asset Management sold 21,872 Natus Medical Inc shares in Q1 2019, an estimated $744K.
  • Baker Avenue Asset Management first reported a position in Natus Medical Inc in Q4 2018 and held it in 1 quarter.
  • Baker Avenue Asset Management's Natus Medical Inc position peaked at $744K in Q4 2018.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Baker Avenue Asset Management's 13F filing for Q1 2019, filed 15 May 2019.